Loading search results
SINGLEKISS
A Multi-center Trial to Evaluate Paclitaxel- and Sirolimus-eluting Stents in Provisional T-stenting With Kissing Balloon Technique in the Treatment of Bifurcation Lesions
Sponsor study identifier
interventional
800
1 country
17
Study Start
June 2007
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
December 2008
Actual (reported)Study Completion
March 2010
Actual (reported)The use of DES have not diminished the need of improved treatment strategies , especially the treatment of bifurcation lesions still leave much to be clarified. Particularly, for bifurcation lesions where stenting the main branch could result in an obstruction of a vital side branch, many reports have been about using 2 drug-eluting stents. Resulting in less than favorable, target lesion revascularization (TLR) rates, with 10-15% for main branch and 11-40% for side branch. In Japan, the PERFECT multi-center registry evaluated outcomes of single stenting plus kissing balloon technique after Directional Coronary Atherectomy (DCA) removal of tissue plaques. TLR rates for both main branch and side branch were a satisfactory 1.3%. However, the DCA technique is mainly suitable for proximal coronary artery lesions, and takes skilled operators. For the treatment of relatively distal bifurcation lesions, where first POBA is performed, then the lesion is stented, followed by kissing balloon technique to fully expand the side branch, is considered a viable treatment. The Toyohashi Heart Center outcomes from August 2004 for this single stent and kissing ballooning technique, using the sirolimus-eluting stent on bifurcation lesions, achieved a satisfactory 5.2% TLR for both main and side branches, suggesting that using two stents may not be necessarily the ideal treatment. The paclitaxel-eluting stent is expected to become available in Japan from June 2007. This stent's cells can be expanded to a maximum of 3.5mm, which should provide a larger lumen access for side-branch treatment. As such, we developed this study to compare the outcomes of paclitaxel-eluting and sirolimus-eluting stents in bifurcation lesions that require side branch dilatation using the kissing ballooning technique.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
March 2010
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 2007
Date type not reportedThis date has not been verified as actual or estimated.
February 12, 2008
Actual (reported)November 27, 2008
Actual (reported)December 2008
Actual (reported)March 2010
Actual (reported)Target lesion revascularization
one year
Drug eluting stents: Comparison Sirolimus with Paclitaxel eluting stents for treatment of coronary bifurcation lesions.
Drug eluting stents: Comparison Sirolimus with Paclitaxel eluting stents for treatment of coronary bifurcation lesions.
These entries preserve how the registry describes the intervention. Their treatment roles are shown separately from molecular identities.
Device product
Paclitaxel-eluting stent (TAXUS)
The registry describes a device or delivery product. Its exact ingredients and actual exposure require separate evidence.
View registry recordHigashi Cardiovascular Clinic
Toyohashi, Aichi-ken, 4400836, Japan
Vulnerable Plaque Society
Toyohashi, Aichi-ken, 4400850, Japan
Toyohashi Heart Center
Toyohashi, Aichi-ken, 4418530, Japan
Teikyo University Chiba Medical Center
Ichihara, Chiba, 2990111, Japan
Southen Tohoku Research Institute
Kōriyama, Fukushima, 9638563, Japan
Gunma Cardiovascular Center
Maebashi, Gunma, 3710004, Japan
Kihara Junkanki Hospital
Asahikawa, Hokkaido, Japan
Kenya Nasu, MD
Toyohashi Heart Center
Yuji Oikawa, MD
Cardiovascular Institute hospital
First Submitted
February 12, 2008
First Posted
November 27, 2008
Study Start
June 2007
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
December 2008
Actual (reported)Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Chitose City Hospital
Chitose, Hokkaido, 0668550, Japan
Hokkaido University Hospital
Sapporo, Hokkaido, 0608648, Japan
Shinko Kagogwa Hospital
Kakogawa, Hyōgo, 6750115, Japan
Sanda City Hospital
Sanda, Hyōgo, 6691321, Japan
Rinku General Medical Center
Izumisano, Osaka, 5980048, Japan
Matsubara Tokushukai Hospital
Matsubara, Osaka, 5800032, Japan
Tokyo Metropolitan Police Hospital
Chiyoda City, Tokyo, 1028161, Japan
Tokyo Medical University Hospital
Shinjuku, Tokyo, 1600023, Japan
Itabashi Chuo Medical Center
tabashi City, Tokyo, 1740051, Japan
Cardiovascular Institute Hospital
Minatoku, Tokyou, 1060032, Japan
Study Completion
March 2010
Actual (reported)Last Updated
June 10, 2010
Record last verified: 2010-06
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: